With extensive expertise in chemistry, pharmacology, biology and biotechnology, the team at Vossius & Partner assists its clients in the customisation of patent prosecution strategies. The practice advises companies from start-ups to multinational, and has extended its offering with expertise in food and green technology patents. Jürgen Meier conducts prosecution and litigation proceedings concerning antibody technology, fermentation technology and microbiology, while Hans-Rainer Jaenichen specialises in biotechnology and pharmaceuticals, and Raphael Salzer is experienced in mechanical and medical engineering. Elard Schenck Zu Schweinsberg focuses on engineering, automotive, material sciences, medical technology and physics patents.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Individual attorneys provide quality products.’
- 'They are extremely knowledgeable and responsive. In particular, we hired them for handling a complex SPC prosecution matter and they proposed very valuable solutions.'
- ‘Super smart and cutting edge in terms of their knowledge of the law. Passionate and involved. Offer creative solutions.’
Key clients
- 3M/Solventum Corporation
- Boston Scientific Corporation
- CRISPR Therapeutics
- Echo Pharmaceuticals
- F. Hoffmann-La Roche AG
- Hitachi Energy
- Hyundai Mobis Co., Ltd.
- IMC Group
- Max-Planck-Gesellschaft
- Newron Pharmaceuticals S.p.A.
- NIO Inc.
- Nippon Steel Corporation
Work highlights
Advised 3M Company and its spinoff Solventum Corporation on EP, DE and PCT filing activities.
Assisted the IMC Group with drafting, prosecution, opposition and infringement proceedings.
Represented the Max Planck Society for the Advancement of Science in various patent prosecution proceedings.
Other key lawyers
Elard Schneck Zu Schweinsberg; Jürgen Meier; Arnold Asmussen; Natalia Berryman; Dirk Harmsen; Hans-Rainer Jaenichen; Philipp Marchand; Raphael Salzer